119 related articles for article (PubMed ID: 26822566)
1. Symmetric 4,4'-(piperidin-4-ylidenemethylene)bisphenol derivatives as novel tunable estrogen receptor (ER) modulators.
Sato M; Ohta K; Kaise A; Aoto S; Endo Y
Bioorg Med Chem; 2016 Mar; 24(5):1089-94. PubMed ID: 26822566
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic activity of bis(4-hydroxyphenyl)methanes with cyclic hydrophobic structure.
Kojima T; Ogawa T; Kitao S; Sato M; Oda A; Ohta K; Endo Y
Bioorg Med Chem; 2015 Nov; 23(21):6900-11. PubMed ID: 26462053
[TBL] [Abstract][Full Text] [Related]
3. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
[TBL] [Abstract][Full Text] [Related]
4. Novel estrogen receptor (ER) modulators: carbamate and thiocarbamate derivatives with m-carborane bisphenol structure.
Ohta K; Ogawa T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Dec; 17(23):7958-63. PubMed ID: 19857971
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of bisphenol A analogs at estrogen receptors (ERs): discovery of an ERα-selective antagonist.
Maruyama K; Nakamura M; Tomoshige S; Sugita K; Makishima M; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2013 Jul; 23(14):4031-6. PubMed ID: 23768907
[TBL] [Abstract][Full Text] [Related]
6. Discovery and total synthesis of a new estrogen receptor heterodimerizing actinopolymorphol A from Actinopolymorpha rutilus.
Huang SX; Powell E; Rajski SR; Zhao LX; Jiang CL; Duan Y; Xu W; Shen B
Org Lett; 2010 Aug; 12(15):3525-7. PubMed ID: 20593804
[TBL] [Abstract][Full Text] [Related]
7. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
[TBL] [Abstract][Full Text] [Related]
8. Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.
Liu H; Bolton JL; Thatcher GR
Chem Res Toxicol; 2006 Jun; 19(6):779-87. PubMed ID: 16780356
[TBL] [Abstract][Full Text] [Related]
9. Bisphenol AF: Halogen bonding effect is a major driving force for the dual ERα-agonist and ERβ-antagonist activities.
Liu X; Suyama K; Shiki J; Torikai K; Nose T; Shimohigashi M; Shimohigashi Y
Bioorg Med Chem; 2020 Feb; 28(3):115274. PubMed ID: 31879182
[TBL] [Abstract][Full Text] [Related]
10. Experimental and computational insights on the recognition mechanism between the estrogen receptor α with bisphenol compounds.
Cao H; Wang F; Liang Y; Wang H; Zhang A; Song M
Arch Toxicol; 2017 Dec; 91(12):3897-3912. PubMed ID: 28616630
[TBL] [Abstract][Full Text] [Related]
11. [Towards bisphenols without hormonal effects].
Balaguer P; Delfosse V; Grimaldi M; Bourguet W
Med Sci (Paris); 2013 Jan; 29(1):14-7. PubMed ID: 23351685
[No Abstract] [Full Text] [Related]
12. Lead identification of a potent benzopyranone selective estrogen receptor modulator.
McKie JA; Bhagwat SS; Brady H; Doubleday M; Gayo L; Hickman M; Jalluri RK; Khammungkhune S; Kois A; Mortensen D; Richard N; Sapienza J; Shevlin G; Stein B; Sutherland M
Bioorg Med Chem Lett; 2004 Jul; 14(13):3407-10. PubMed ID: 15177442
[TBL] [Abstract][Full Text] [Related]
13. Novel estrogen receptor (ER) modulators containing various hydrophobic bent-core structures.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem; 2014 Jul; 22(13):3508-14. PubMed ID: 24837157
[TBL] [Abstract][Full Text] [Related]
14. Computational insights on agonist and antagonist mechanisms of estrogen receptor α induced by bisphenol A analogues.
Cao H; Wang L; Cao M; Ye T; Sun Y
Environ Pollut; 2019 May; 248():536-545. PubMed ID: 30831350
[TBL] [Abstract][Full Text] [Related]
15. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
16. From ligand structure to biological activity: modified estratrienes and their estrogenic and antiestrogenic effects in MCF-7 cells.
Brooks SC; Skafar DF
Steroids; 2004 Jun; 69(6):401-18. PubMed ID: 15219790
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity.
Lubczyk V; Bachmann H; Gust R
J Med Chem; 2003 Apr; 46(8):1484-91. PubMed ID: 12672249
[TBL] [Abstract][Full Text] [Related]
18. Design and Synthesis of Novel Breast Cancer Therapeutic Drug Candidates Based upon the Hydrophobic Feedback Approach of Antiestrogens.
Ohta K; Kaise A; Taguchi F; Aoto S; Ogawa T; Endo Y
Molecules; 2019 Nov; 24(21):. PubMed ID: 31683895
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators.
Lloyd DG; Smith HM; O'Sullivan T; Zisterer DM; Meegan MJ
Med Chem; 2005 Jul; 1(4):335-53. PubMed ID: 16789891
[TBL] [Abstract][Full Text] [Related]
20. Phosphine boranes as less hydrophobic building blocks than alkanes and silanes: Structure-property relationship and estrogen-receptor-modulating potency of 4-phosphinophenol derivatives.
Saito H; Matsumoto Y; Hashimoto Y; Fujii S
Bioorg Med Chem; 2020 Feb; 28(4):115310. PubMed ID: 31980362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
